IL-8 could be considered a good biomarker to follow COPD patients during exacerbations because some studies [33] demonstrated that exacerbated patients exhibit higher levels of circulating IL-8 than stable COPD patients. The gene discussed is CXCL8; the disease is chronic obstructive pulmonary disease.